Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950103-25-011896
Filing Date
2025-09-19
Accepted
2025-09-19 16:14:24
Documents
12
Period of Report
2025-09-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A dp234578_8ka-1.htm   iXBRL 8-K/A 22800
  Complete submission text file 0000950103-25-011896.txt   187214

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE crl-20250912.xsd EX-101.SCH 2996
3 XBRL LABEL FILE crl-20250912_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE crl-20250912_pre.xml EX-101.PRE 22347
14 EXTRACTED XBRL INSTANCE DOCUMENT dp234578_8ka-1_htm.xml XML 3694
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1227
Type: 8-K/A | Act: 34 | File No.: 001-15943 | Film No.: 251326989
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)